Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
5
Alimentos
2
Antologías
2
Excavaciones arqueológicas
2
Historia y crítica
2
Literatura mexicana
2
Medicina
2
Nutrición
2
Poesía cubana
2
Agricultura
1
Agroecosistema
1
Agroecosystem
1
Anatomía humana
1
Antiguedades
1
Antigüedades
1
Análisis
1
Arquitectos
1
Artes gráficas
1
Aspectos económicos
1
Aves de corral
1
Avicultura
1
Bibliografías
1
Biografías
1
Color
1
Color en diseño gráfico
1
Color en el arte
1
Comunicación visual
1
Confección de joyas
1
Corriente alterna
1
Desarrollo sostenible
1
-
2201por Khan, Rehana, Chandra, Shruti, Rajalakshmi, Ramachandran, Rani, Padmaja Kumari, Anantharaman, Giridhar, Sen, Alok, Desai, Abhishek, Roy, Rupak, Natarajan, Sundaram, Chen, Lanin, Chawla, Gajendra, Behera, Umesh Chandra, Gopal, Lingam, Gurudas, Sarega, Sivaprasad, Sobha, Raman, RajivEnlace del recurso
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2202por Wu, Chen‐Fei, Lv, Jia‐Wei, Lin, Li, Mao, Yan‐Ping, Deng, Bin, Zheng, Wei‐Hong, Wen, Dan‐Wan, Chen, Yue, Kou, Jia, Chen, Fo‐Ping, Yang, Xing‐Li, Zheng, Zi‐Qi, Li, Zhi‐Xuan, Xu, Si‐Si, Ma, Jun, Sun, Ying“…Crude CS estimates of conditional overall survival (COS), conditional disease‐free survival (CDFS), conditional locoregional relapse‐free survival (CLRRFS), conditional distant metastasis‐free survival (CDMFS), and conditional NPC‐specific survival (CNPC‐SS) were calculated. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2203“…The impact of the high estrogen environment during COS on the birth weight of IVF offspring still needs future research.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2204“…BACKGROUND: It is the duty of doctors to choose a safe, simple, economic and effective controlled ovulation stimulation (COS) protocol for the patients. This study aims to compare the clinical effects of the early follicular prolonged GnRH agonist (EFPL) and GnRH antagonist (GnRH-Ant) protocols, hoping to provide some reference for clinicians when choosing COS program. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2205por Abe, K., Andreopoulos, C., Antonova, M., Aoki, S., Ariga, A., Assylbekov, S., Autiero, D., Ban, S., Barbi, M., Barker, G.J., Barr, G., Bartet-Friburg, P., Batkiewicz, M., Bay, F., Berardi, V., Berkman, S., Bhadra, S., Bienstock, S., Blondel, A., Bolognesi, S., Bordoni, S., Boyd, S.B., Brailsford, D., Bravar, A., Bronner, C., Avanzini, M. Buizza, Calland, R.G., Campbell, T., Cao, S., Rodríguez, J. Caravaca, Cartwright, S.L., Castillo, R., Catanesi, M.G., Cervera, A., Cherdack, D., Chikuma, N., Christodoulou, G., Clifton, A., Coleman, J., Collazuol, G., Coplowe, D., Cremonesi, L., Dabrowska, A., De Rosa, G., Dealtry, T., Denner, P.F., Dennis, S.R., Densham, C., Dewhurst, D., Di Lodovico, F., Di Luise, S., Dolan, S., Drapier, O., Duffy, K.E., Dumarchez, J., Dytman, S., Dziewiecki, M., Emery-Schrenk, S., Ereditato, A., Feusels, T., Finch, A.J., Fiorentini, G.A., Friend, M., Fujii, Y., Fukuda, D., Fukuda, Y., Furmanski, A.P., Galymov, V., Garcia, A., Giffin, S.G., Giganti, C., Gilje, K., Gizzarelli, F., Gonin, M., Grant, N., Hadley, D.R., Haegel, L., Haigh, M.D., Hamilton, P., Hansen, D., Harada, J., Hara, T., Hartz, M., Hasegawa, T., Hastings, N.C., Hayashino, T., Hayato, Y., Helmer, R.L., Hierholzer, M., Hillairet, A., Himmel, A., Hiraki, T., Hirota, S., Hogan, M., Holeczek, J., Horikawa, S., Hosomi, F., Huang, K., Ichikawa, A.K., Ieki, K., Ikeda, M., Imber, J., Insler, J., Intonti, R.A., Irvine, T.J., Ishida, T., Ishii, T., Iwai, E., Iwamoto, K., Izmaylov, A., Jacob, A., Jamieson, B., Jiang, M., Johnson, S., Jo, J.H., Jonsson, P., Jung, C.K., Kabirnezhad, M., Kaboth, A.C., Kajita, T., Kakuno, H., Kameda, J., Karlen, D., Karpikov, I., Katori, T., Kearns, E., Khabibullin, M., Khotjantsev, A., Kielczewska, D., Kikawa, T., Kim, H., Kim, J., King, S., Kisiel, J., Knight, A., Knox, A., Kobayashi, T., Koch, L., Koga, T., Konaka, A., Kondo, K., Kopylov, A., Kormos, L.L., Korzenev, A., Koshio, Y., Kropp, W., Kudenko, Y., Kurjata, R., Kutter, T., Lagoda, J., Lamont, I., Larkin, E., Lasorak, P., Laveder, M., Lawe, M., Lazos, M., Lindner, T., Liptak, Z.J., Litchfield, R.P., Li, X., Longhin, A., Lopez, J.P., Lou, T., Ludovici, L., Lu, X., Magaletti, L., Mahn, K., Malek, M., Manly, S., Marino, A.D., Marteau, J., Martin, J.F., Martins, P., Martynenko, S., Maruyama, T., Matveev, V., Mavrokoridis, K., Ma, W.Y., Mazzucato, E., McCarthy, M., McCauley, N., McFarland, K.S., McGrew, C., Mefodiev, A., Metelko, C., Mezzetto, M., Mijakowski, P., Miller, C.A., Minamino, A., Mineev, O., Mine, S., Missert, A., Miura, M., Moriyama, S., Mueller, Th. A., Murphy, S., Myslik, J., Nakadaira, T., Nakahata, M., Nakamura, K.G., Nakamura, K., Nakamura, K.D., Nakayama, S., Nakaya, T., Nakayoshi, K., Nantais, C., Nielsen, C., Nirkko, M., Nishikawa, K., Nishimura, Y., Novella, P., Nowak, J., O'Keeffe, H.M., Ohta, R., Okumura, K., Okusawa, T., Oryszczak, W., Oser, S.M., Ovsyannikova, T., Owen, R.A., Oyama, Y., Palladino, V., Palomino, J.L., Paolone, V., Patel, N.D., Pavin, M., Payne, D., Perkin, J.D., Petrov, Y., Pickard, L., Pickering, L., Pinzon Guerra, E. S., Pistillo, C., Popov, B., Posiadala-Zezula, M., Poutissou, J. -M., Poutissou, R., Przewlocki, P., Quilain, B., Radermacher, T., Radicioni, E., Ratoff, P.N., Ravonel, M., Rayner, M.A.M., Redij, A., Reinherz-Aronis, E., Riccio, C., Rojas, P., Rondio, E., Roth, S., Rubbia, A., Rychter, A., Sacco, R., Sakashita, K., Sánchez, F., Sato, F., Scantamburlo, E., Scholberg, K., Schoppmann, S., Schwehr, J., Scott, M., Seiya, Y., Sekiguchi, T., Sekiya, H., Sgalaberna, D., Shah, R., Shaikhiev, A., Shaker, F., Shaw, D., Shiozawa, M., Shirahige, T., Short, S., Smy, M., Sobczyk, J.T., Sobel, H., Sorel, M., Southwell, L., Stamoulis, P., Steinmann, J., Stewart, T., Stowell, P., Suda, Y., Suvorov, S., Suzuki, A., Suzuki, K., Suzuki, S.Y., Suzuki, Y., Tacik, R., Tada, M., Takahashi, S., Takeda, A., Takeuchi, Y., Tanaka, H.K., Tanaka, H.A., Terhorst, D., Terri, R., Thakore, T., Thompson, L.F., Tobayama, S., Toki, W., Tomura, T., Touramanis, C., Tsukamoto, T., Tzanov, M., Uchida, Y., Vacheret, A., Vagins, M., Vallari, Z., Vasseur, G., Wachala, T., Wakamatsu, K., Walter, C.W., Wark, D., Warzycha, W., Wascko, M.O., Weber, A., Wendell, R., Wilkes, R.J., Wilking, M.J., Wilkinson, C., Wilson, J.R., Wilson, R.J., Yamada, Y., Yamamoto, K., Yamamoto, M., Yanagisawa, C., Yano, T., Yen, S., Yershov, N., Yokoyama, M., Yoo, J., Yoshida, K., Yuan, T., Yu, M., Zalewska, A., Zalipska, J., Zambelli, L., Zaremba, K., Ziembicki, M., Zimmerman, E.D., Zito, M., Zmuda, J. .Enlace del recurso
Publicado 2016
Enlace del recurso
-
2206“…The neutrino mixing sum rule $\theta_{12} - \theta_{13}\cos(\delta) \approx \theta^\nu_{12}$ provides a possibility to explore the structure of the neutrino mass matrix in the presence of charged lepton corrections, since it relates the 1-2 mixing angle from the neutrino mass matrix, $\theta_{12}^\nu$, to observable parameters of the PMNS mixing matrix. …”
Enlace del recurso
Enlace del recurso
-
2207por Hu, Qipeng“…Fourier coefficients associated with the cos(2(phi-Psi_{2})) modulation, v2 , are measured as a function of pT and centrality. …”
Publicado 2016
Enlace del recurso
-
2208por Buran, T, Baglin, C, Briandet, P, Carlson, P J, D'Almagne, B, De Rosny, G, Eide, A, Fleury, P, Gracco, Valerio, Helgaker, P, Johansson, K E, Lehmann, P, Lundby, Arne, Navarro-Savoy, A, Richard, F, Sorum, O, Staurset, L, Thénard, J M, Treille, D“…Large- angle pi /sup -/p scattering differential cross sections oscillate around an average differential cross section of 50 nb/(GeV/c)/sup 2/, with minima at cos theta /sub cm/ approximately=0 and -0.4. The well- known dip at -t=2.8 (GeV/c)/sup 2/ remains constant in t. …”
Publicado 1976
Enlace del recurso
Enlace del recurso
-
2209por Ferracin, P, Ambrosio, G, Anerella, M, Bingham, B, Bossert, R, Caspi, S, Cheng, D W, Chlachidze, G, Felice, H, Hafalia, A R, Hannaford, C R, Mumper, W, Nobrega, F, Prestemon, S, Sabbi, G L, Schmalzle, J, Sylvester, C, Tartaglia, M, Wanderer, P, Zlobin, A V“…The LQS01 design, a scale-up of the 1 m long Technology Quadrupole TQS, includes four 3.4 m long cos(theta) coils contained in a support structure based on four 1 m long aluminum shells pre-tensioned with water-pressurized bladders (shell-type structure). …”
Publicado 2010
Enlace del recurso
Enlace del recurso
-
2210por Shahane, Kiran, Kshirsagar, Madhuri, Tambe, Srushti, Jain, Divya, Rout, Srutee, Ferreira, Maria Karolina Martins, Mali, Suraj, Amin, Purnima, Srivastav, Prem Prakash, Cruz, Jorddy, Lima, Rafael Rodrigues“…We have also elucidated CO’s molecular mechanisms and recent clinical studies. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2211por Shakhpazyan, Nikolay, Mikhaleva, Liudmila, Bedzhanyan, Arkady, Gioeva, Zarina, Sadykhov, Nikolay, Mikhalev, Alexander, Atiakshin, Dmitri, Buchwalow, Igor, Tiemann, Markus, Orekhov, Alexander“…The review also identifies conserved oncogenic signatures (COS) within CRC stroma and explores their potential as therapeutic targets. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2212por Ingrungruengluet, Pattarachat, Wang, Dingfu, Li, Xin, Yang, Cheng, Waiprib, Yaowapha, Li, Chunxia“…This research aimed to fabricate a water-soluble CU nano-formulation with chitooligosaccharides (COS) and pluronic F-68 (PF) utilizing the polymeric micelle method. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2213Publicado 1990“…In pulse-chase experiments in COS cells, nonglycosylated VP7 was still detectable after a 25-min chase period, although the single glycosylation site was only 18 residues beyond the signal peptide cleavage site. …”
Enlace del recurso
Enlace del recurso
Texto -
2214Publicado 1993“…We have now transfected cultured mammalian COS-7 cells with both wild-type and mutant dynamin cDNAs. …”
Enlace del recurso
Enlace del recurso
Texto -
2215Publicado 1996“…Previous experiments have suggested that het erodimer formation in the ER arises from interaction between the luminal, NH2-terminal domains of the subunits. When expressed in COS cells with the delta subunit, however, the truncated NH2-terminal domain of the subunit folded correctly but did not form a heterodimer. …”
Enlace del recurso
Enlace del recurso
Texto -
2216Publicado 1996“…Binding studies using transfected COS7 cells and immunoprecipitations reveal a direct interaction between neurofascin and NrCAM. …”
Enlace del recurso
Enlace del recurso
Texto -
2217Publicado 1990“…In this report we describe the isolation and functional expression of a human IL-4-R cDNA. When transfected into COS-7 cells, the cDNA encodes a 140-kD cell-surface protein. …”
Enlace del recurso
Enlace del recurso
Texto -
2218Publicado 1987“…Recombinant granulocyte/macrophage colony-stimulating factor (rGM-CSF) obtained from cloned complementary Mo cell DNA and expressed in COS-1 cells activates cultured peripheral blood monocyte-derived macrophages in vitro to become cytotoxic for intracellular L. donovani. …”
Enlace del recurso
Enlace del recurso
Texto -
2219Publicado 1994“…Expression of different regions of the P. vivax protein in COS7 cells identified a cysteine-rich domain that bound Duffy blood group-positive but not Duffy blood group-negative human erythrocytes. …”
Enlace del recurso
Enlace del recurso
Texto -
2220Publicado 1994“…When expressed from cDNA in COS-1 cells, wild-type msALDH is localized exclusively in the well-developed ER. …”
Enlace del recurso
Enlace del recurso
Texto